Literature DB >> 20647405

No association between FTO or HHEX and endometrial cancer risk.

Mia M Gaudet1, Hannah P Yang, Jesus Gonzalez Bosquet, Catherine S Healey, Shahana Ahmed, Alison M Dunning, Doug F Easton, Amanda B Spurdle, Kaltin Ferguson, Tracy O'Mara, Diether Lambrechts, Evelyn Despierre, Ignace Vergote, Frederic Amant, James V Lacey, Jola Lissowska, Beata Peplonska, Louise A Brinton, Stephen Chanock, Montserrat Garcia-Closas.   

Abstract

INTRODUCTION: Obesity and diabetes are known risk factors for endometrial cancer; thus, the genetic risk factors of these phenotypes might also be associated with endometrial cancer risk. To evaluate this hypothesis, we genotyped tag-single nucleotide polymorphisms (SNP) and candidate SNPs in FTO and HHEX in a primary set of 417 endometrial cancer cases and 406 population-based controls, and validated significant findings in a replication set of approximately 2,347 cases and 3,140 controls from three additional studies.
METHODS: We genotyped 189 tagSNPs in FTO (including rs8050136) and five tagSNPs in HHEX (including rs1111875) in the primary set and one SNP each in FTO (rs12927155) and HHEX (rs1111875) in the validation set. Per allele odds ratios (OR) and 95% confidence intervals (CI) were calculated to estimate the association between the genotypes of each SNPs (as an ordinal variable) and endometrial cancer risk using unconditional logistic regression models, controlling for age and site.
RESULTS: In the primary study, the most significant finding in FTO was rs12927155 (OR, 1.56; 95% CI, 1.21-2.01; P = 5.8 x 10(-4)), and in HHEX, it was rs1111875 (OR, 0.80; 95% CI, 0.66-0.97; P = 0.026). In the validation studies, the pooled per allele OR, adjusted for age and study for FTO, was rs12927155 (OR, 0.94; 95% CI, 0.83-1.06; P = 0.29), whereas for HHEX, it was rs1111875 (OR, 1.00; 95% CI, 0.92-1.10; P = 0.96).
CONCLUSION: Our data indicate that common genetic variants in two genes previously related to obesity (FTO) and diabetes (HHEX) by genome-wide association scans were not associated with endometrial cancer risk. IMPACT: Polymorphisms in FTO and HHEX are unlikely to have large effects on endometrial cancer risk but may have weaker effects. (c)2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20647405      PMCID: PMC2919629          DOI: 10.1158/1055-9965.EPI-10-0515

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  8 in total

1.  Sequential haplotype scan methods for association analysis.

Authors:  Zhaoxia Yu; Daniel J Schaid
Journal:  Genet Epidemiol       Date:  2007-09       Impact factor: 2.135

2.  Re: Excess of early onset multiple myeloma in endometrial cancer probands and their relatives suggests common susceptibility.

Authors:  Amanda Spurdle; Penelope Webb
Journal:  Gynecol Oncol       Date:  2008-01-29       Impact factor: 5.482

3.  Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples.

Authors:  Bao-Zhu Yang; Henry R Kranzler; Hongyu Zhao; Jeffrey R Gruen; Xingguang Luo; Joel Gelernter
Journal:  Hum Mol Genet       Date:  2007-08-30       Impact factor: 6.150

4.  Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes.

Authors:  Hannah P Yang; Jesus Gonzalez Bosquet; Qizhai Li; Elizabeth A Platz; Louise A Brinton; Mark E Sherman; James V Lacey; Mia M Gaudet; Laurie A Burdette; Jonine D Figueroa; Julia G Ciampa; Jolanta Lissowska; Beata Peplonska; Stephen J Chanock; Montserrat Garcia-Closas
Journal:  Carcinogenesis       Date:  2010-01-06       Impact factor: 4.944

5.  Genetic variation in CYP17 and endometrial cancer risk.

Authors:  Mia M Gaudet; James V Lacey; Jolanta Lissowska; Beata Peplonska; Louise A Brinton; Stephen Chanock; Montserrat Garcia-Closas
Journal:  Hum Genet       Date:  2008-01-03       Impact factor: 4.132

6.  Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome.

Authors:  Ioannis Kalogiannidis; Sandrijne Lambrechts; Frederic Amant; Patrick Neven; Toon Van Gorp; Ignace Vergote
Journal:  Am J Obstet Gynecol       Date:  2007-03       Impact factor: 8.661

7.  A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity.

Authors:  Timothy M Frayling; Nicholas J Timpson; Michael N Weedon; Eleftheria Zeggini; Rachel M Freathy; Cecilia M Lindgren; John R B Perry; Katherine S Elliott; Hana Lango; Nigel W Rayner; Beverley Shields; Lorna W Harries; Jeffrey C Barrett; Sian Ellard; Christopher J Groves; Bridget Knight; Ann-Marie Patch; Andrew R Ness; Shah Ebrahim; Debbie A Lawlor; Susan M Ring; Yoav Ben-Shlomo; Marjo-Riitta Jarvelin; Ulla Sovio; Amanda J Bennett; David Melzer; Luigi Ferrucci; Ruth J F Loos; Inês Barroso; Nicholas J Wareham; Fredrik Karpe; Katharine R Owen; Lon R Cardon; Mark Walker; Graham A Hitman; Colin N A Palmer; Alex S F Doney; Andrew D Morris; George Davey Smith; Andrew T Hattersley; Mark I McCarthy
Journal:  Science       Date:  2007-04-12       Impact factor: 47.728

8.  A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.

Authors:  Laura J Scott; Karen L Mohlke; Lori L Bonnycastle; Cristen J Willer; Yun Li; William L Duren; Michael R Erdos; Heather M Stringham; Peter S Chines; Anne U Jackson; Ludmila Prokunina-Olsson; Chia-Jen Ding; Amy J Swift; Narisu Narisu; Tianle Hu; Randall Pruim; Rui Xiao; Xiao-Yi Li; Karen N Conneely; Nancy L Riebow; Andrew G Sprau; Maurine Tong; Peggy P White; Kurt N Hetrick; Michael W Barnhart; Craig W Bark; Janet L Goldstein; Lee Watkins; Fang Xiang; Jouko Saramies; Thomas A Buchanan; Richard M Watanabe; Timo T Valle; Leena Kinnunen; Gonçalo R Abecasis; Elizabeth W Pugh; Kimberly F Doheny; Richard N Bergman; Jaakko Tuomilehto; Francis S Collins; Michael Boehnke
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

  8 in total
  12 in total

1.  Association between the FTOrs8050136 polymorphism and cancer risk: a meta-analysis.

Authors:  Jian Zhao; Xiaoyi Huang; Mingyuan Yang; Ming Li; Jianming Zheng
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

2.  FTO gene polymorphisms and hepatoblastoma susceptibility among Chinese children.

Authors:  Junzhen Fan; Zhenjian Zhuo; Guoqing Chen; Huizhong Niu; Zhonghua Yang; Jiao Zhang; Yong Li; Suhong Li; Jiwen Cheng; Li Li; Jing He; Xianqiang Wang
Journal:  Cell Cycle       Date:  2022-03-23       Impact factor: 5.173

3.  Association between FTO gene polymorphism and cancer risk: evidence from 16,277 cases and 31,153 controls.

Authors:  Guiqiong Li; Qingwei Chen; Li Wang; Dazhi Ke; Zhongming Yuan
Journal:  Tumour Biol       Date:  2012-03-07

4.  CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer risk.

Authors:  Tracy A O'Mara; Kaltin Ferguson; Paul Fahey; Louise Marquart; Hannah P Yang; Jolanta Lissowska; Stephen Chanock; Montserrat Garcia-Closas; Deborah J Thompson; Catherine S Healey; Alison M Dunning; Douglas F Easton; Penelope M Webb; Amanda B Spurdle
Journal:  Twin Res Hum Genet       Date:  2011-08       Impact factor: 1.587

5.  Fat mass and obesity-associated gene polymorphisms, pre-diagnostic plasma adipokine levels and the risk of colorectal cancer: The Japan Public Health Center-based Prospective Study.

Authors:  Taiki Yamaji; Motoki Iwasaki; Norie Sawada; Taichi Shimazu; Manami Inoue; Shoichiro Tsugane
Journal:  PLoS One       Date:  2020-02-13       Impact factor: 3.240

6.  No Association Between FTO Gene Polymorphisms and Central Nervous System Tumor Susceptibility in Chinese Children.

Authors:  Yuxiang Liao; Li Yuan; Zhiping Zhang; Ao Lin; Jingying Zhou; Zhenjian Zhuo; Jie Zhao
Journal:  Pharmgenomics Pers Med       Date:  2021-01-19

Review 7.  The Potential Role of N6-Methyladenosine (m6A) Demethylase Fat Mass and Obesity-Associated Gene (FTO) in Human Cancers.

Authors:  Jin-Yan Wang; Li-Juan Chen; Ping Qiang
Journal:  Onco Targets Ther       Date:  2020-12-15       Impact factor: 4.147

Review 8.  The bigger picture of FTO: the first GWAS-identified obesity gene.

Authors:  Ruth J F Loos; Giles S H Yeo
Journal:  Nat Rev Endocrinol       Date:  2013-11-19       Impact factor: 43.330

9.  Body Mass Index Genetic Risk Score and Endometrial Cancer Risk.

Authors:  Jennifer Prescott; Veronica W Setiawan; Nicolas Wentzensen; Fredrick Schumacher; Herbert Yu; Ryan Delahanty; Leslie Bernstein; Stephen J Chanock; Chu Chen; Linda S Cook; Christine Friedenreich; Monserrat Garcia-Closas; Christopher A Haiman; Loic Le Marchand; Xiaolin Liang; Jolanta Lissowska; Lingeng Lu; Anthony M Magliocco; Sara H Olson; Harvey A Risch; Xiao-Ou Shu; Giske Ursin; Hannah P Yang; Peter Kraft; Immaculata De Vivo
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

10.  Is FTO gene variant related to cancer risk independently of adiposity? An updated meta-analysis of 129,467 cases and 290,633 controls.

Authors:  Yu Kang; Fang Liu; Yao Liu
Journal:  Oncotarget       Date:  2017-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.